2023-11-10 15:32:29
They are the “fashionable” medications. The wave of weight loss drugs It does not stop growing. And its dangers are announced. They are treatments, generally, diabetes employeesbut they have certain properties to lose weight (or so their manufacturers say in an interested way).
The business, because what we are talking about here is money rather than health, is tremendous: more than one billion people are expected to be obese by the year 2030, according to the World Obesity Federation.
In the United States, the Food and Drug Administration (FDA) has already approved the use of injectable tirzepatide (brand Mounjaro) for chronic weight control in adults with obesity. The same drug, was already authorized to be indicated in adult patients with type 2 diabetes.
Next, it has been the European Medicines Agency (EMA) which has given the approval for marketing. The “fever” to lose weight with them began with Ozempic which, as we have said, is even changing shopping habits in supermarkets.
The problem is that these drugs are being misused. Ozempic was approved in 2017 by the US drug agency, the FDA, to treat type 2 diabetes. NOT to lose weight.
What you have achieved Eli Lillythe manufacturer of Mounjaro, is a great marketing success: convincing health authorities that its product does help you lose weight.
Foto de Towfiqu Barbhuiya.
Marketing, sales, happy investors, great business, “impressive” effectiveness (only 5% weight loss), but it is worth asking, as we did a few months ago: A diabetes drug like Ozempic that can cause suicide? That is, is anyone concerned about the safety of the population?
The technical sheet (the document to which we must go whenever we want know a drug) by Mounjaroquote in its section Special warnings and precautions for use acute pancreatitis. Hypoglycemia has also been associated with gastrointestinal adverse reactionswhich can lead to dehydration, which could lead to deterioration in kidney function and acute kidney failure.
But it has not been studied in patients with severe gastrointestinal illness. As it has not been tested in patients with diabetic retinopathy. As there are no or limited data regarding the use of tirzepatide in pregnant women.
Additionally, it is unknown whether tirzepatide is excreted in breast milk. You cannot exclude a risk for the newborns/infants. And the effect of tirzepatide on fertility in humans is unknown.
In the United States, the FDA warns that it should not be used in patients with a personal or family history of medullary thyroid cancer, nor in patients with multiple endocrine neoplasia type II. Many unresolved doubts.
And while the doubts are resolved, we do know that these drugs used to lose weight begin their journey with the “insurance” label and then their damages become known as they go. It is almost always like this. Read Serious side effects of new weight control pills.
Anyway, choose other methods to lose weight and don’t risk it.
If you or a family member or acquaintance has suffered damage Contact us to analyze your case.
Related
#drug #joins #fashion #losing #weight #injections #pills